Erratum: Cost-effectiveness of Antenatal Corticosteroid Therapy vsNo Therapy in Women at Risk of Late Preterm Delivery: A Secondary Analysis of a Randomized Clinical Trial (JAMA Pediatr. DOI: 10.1001/jamapediatrics.2019.0032);Cost-effectiveness of Antenatal Corticosteroid Therapy vs No Therapy in Women at Risk of Late Preterm Delivery: A Secondary Analysis of a Randomized Clinical Trial

JAMA Pediatrics

Volumn 173, Issue 5, 2019, Pages 462-468

  Gyamfi Bannerman, Cynthia ^a   Zupancic, John A F ^b   Sandoval, Grecio ^c   Grobman, William A ^d   Blackwell, Sean C ^e   Tita, Alan T N ^f   Reddy, Uma M ^g   Jain, Lucky ^h   Saade, George R ⁱ   Rouse, Dwight J ^j   Iams, Jay D ^k   Clark, Erin A S ^l   Thorp, John M ^m   Chien, Edward K ⁿ   Peaceman, Alan M ^d   Gibbs, Ronald S ^o   Swamy, Geeta K ^p   Norton, Mary E ^q   Casey, Brian M ^r   Caritis, Steve N ^s   Tolosa, Jorge E ^t   Sorokin, Yoram ^u   Vandorsten, J Peter ^v   more..

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ University of Texas Medical Branch School of Medicine   (United States)

^j BROWN UNIVERSITY   (United States)

^k OHIO STATE UNIVERSITY   (United States)

^l UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

ⁿ METROHEALTH MEDICAL CENTER   (United States)

^o UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^p DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q STANFORD UNIVERSITY   (United States)

^r UNIVERSITY OF TEXAS AT DALLAS   (United States)

^s UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^t OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^u WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; GLUCOCORTICOID;

ADULT; CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG ADMINISTRATION; ECONOMICS; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; MALE; MULTICENTER STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PREGNANCY; PREMATURITY; PRENATAL CARE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; UNITED STATES;

ADULT; BETAMETHASONE; COST-BENEFIT ANALYSIS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEALTH CARE COSTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PREGNANCY; PREMATURE BIRTH; PRENATAL CARE; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK ASSESSMENT; UNITED STATES;

EID: 85062665548     PISSN: 21686203     EISSN: 21686211     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2019.0994     Document Type: Erratum

References (37)

1. Russell RB, Green NS, Steiner CA, Cost of hospitalization for preterm and low birth weight infants in the United States. Pediatrics. 2007; 120 (1): e1-e9. doi: 10.1542/peds.2006-2386 17606536
2. Martin JA, Hamilton BE, Osterman MJ, Driscoll AK, Mathews TJ. Births: final data for 2015. Natl Vital Stat Rep. 2017; 66 (1): 1. 28135188
3. McIntire DD, Leveno KJ. Neonatal mortality and morbidity rates in late preterm births compared with births at term. Obstet Gynecol. 2008; 111 (1): 35-41. doi: 10.1097/01.AOG.0000297311.33046.73 18165390
4. Yoder BA, Gordon MC, Barth WH Jr. Late-preterm birth: does the changing obstetric paradigm alter the epidemiology of respiratory complications? Obstet Gynecol. 2008; 111 (4): 814-822. doi: 10.1097/AOG.0b013e31816499f4 18378739
5. Hibbard JU, Wilkins I, Sun L,; Consortium on Safe Labor. Respiratory morbidity in late preterm births. JAMA. 2010; 304 (4): 419-425. doi: 10.1001/jama.2010.1015 20664042
6. Gyamfi-Bannerman C. The scope of the problem: the epidemiology of late preterm and early-term birth. Semin Perinatol. 2011; 35 (5): 246-248. doi: 10.1053/j.semperi.2011.05.013 21962621
7. Jacob J, Lehne M, Mischker A, Klinger N, Zickermann C, Walker J. Cost effects of preterm birth: a comparison of health care costs associated with early preterm, late preterm, and full-term birth in the first 3 years after birth. Eur J Health Econ. 2017; 18 (8): 1041-1046. doi: 10.1007/s10198-016-0850-x 27909819
8. Bérard A, Le Tiec M, De Vera MA. Study of the costs and morbidities of late-preterm birth. Arch Dis Child Fetal Neonatal Ed. 2012; 97 (5): F329-F334. doi: 10.1136/fetalneonatal-2011-300969 22933090
9. McLaurin KK, Hall CB, Jackson EA, Owens OV, Mahadevia PJ. Persistence of morbidity and cost differences between late-preterm and term infants during the first year of life. Pediatrics. 2009; 123 (2): 653-659. doi: 10.1542/peds.2008-1439 19171634
10. Khan KA, Petrou S, Dritsaki M, Economic costs associated with moderate and late preterm birth: a prospective population-based study. BJOG. 2015; 122 (11): 1495-1505. doi: 10.1111/1471-0528.13515 26219352
11. Aly H, Hoffman H, El-Dib M, Said L, Mohamed M. Factor affecting length of stay in late preterm infants: an US national database study. J Matern Fetal Neonatal Med. 2015; 28 (5): 598-604. doi: 10.3109/14767058.2014.927428 24853492
12. Zupancic JA, Dukhovny D. Resource distribution in neonatology: beyond the Pareto principle. Arch Dis Child Fetal Neonatal Ed. 2015; 100 (6): F472-F473. doi: 10.1136/archdischild-2014-308136 26152735
13. Petrou S, Khan K. Economic costs associated with moderate and late preterm birth: primary and secondary evidence. Semin Fetal Neonatal Med. 2012; 17 (3): 170-178. doi: 10.1016/j.siny.2012.02.001 22364679
14. Phibbs CS, Schmitt SK, Cooper M, Birth hospitalization costs and days of care for mothers and neonates in California, 2009-2011. J Pediatr. 2019; 204: 118-125.e14. doi: 10.1016/j.jpeds.2018.08.041 30297293
15. Gyamfi-Bannerman C, Thom EA, Blackwell SC,; NICHD Maternal-Fetal Medicine Units Network. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med. 2016; 374 (14): 1311-1320. doi: 10.1056/NEJMoa1516783 26842679
16. Society for Maternal-Fetal Medicine (SMFM) Publications Committee. Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery. Am J Obstet Gynecol. 2016; 215 (2): B13-B15. doi: 10.1016/j.ajog.2016.03.013 26992737
17. Committee on Obstetric Practice. Committee Opinion No. 713: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2017; 130 (2): e102-e109. doi: 10.1097/AOG.0000000000002237 28742678
18. Nicholson WK, Frick KD, Powe NR. Economic burden of hospitalizations for preterm labor in the United States. Obstet Gynecol. 2000; 96 (1): 95-101. 10862850
19. Centers for Medicare & Medicaid Services Physician Fee Schedule Look-Up Tool. 2015. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PFSlookup/index.html. Accessed March 1, 2018.
20. Zupancic JA, Hibbs AM, Palermo L,; NO CLD Trial Group. Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation. Pediatrics. 2009; 124 (5): 1325-1332. doi: 10.1542/peds.2008-3214 19841125
21. Mowitz ME, Zupancic JA, Millar D, Prospective economic evaluation alongside the non-invasive ventilation trial. J Perinatol. 2017; 37 (1): 61-66. doi: 10.1038/jp.2016.159 27684419
22. Barradas DT, Wasserman MP, Daniel-Robinson L, Hospital utilization and costs among preterm infants by payer: nationwide inpatient sample, 2009. Matern Child Health J. 2016; 20 (4): 808-818. doi: 10.1007/s10995-015-1911-y 26740227
23. Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey. https://meps.ahrq.gov/about_meps/Price_Index.shtml. Accessed November 1, 2018.
24. Dunn A, Grosse SD, Zuvekas SH. Adjusting health expenditures for inflation: a review of measures for health services research in the United States. Health Serv Res. 2018; 53 (1): 175-196. doi: 10.1111/1475-6773.12612 27873305
25. Blough DK, Madden CW, Hornbrook MC. Modeling risk using generalized linear models. J Health Econ. 1999; 18 (2): 153-171. doi: 10.1016/S0167-6296(98)00032-0 10346351
26. Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ. 2005; 24 (3): 465-488. doi: 10.1016/j.jhealeco.2004.09.011 15811539
27. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001; 20 (4): 461-494. doi: 10.1016/S0167-6296(01)00086-8 11469231
28. Glick HA, Doshi JA, Sonnad SS, Polsky D, eds. Economic Evaluation in Clinical Trials. Oxford, England: Oxford University Press; 2014, doi: 10.1093/med/9780199685028.001.0001
29. Ramsey SD, Willke RJ, Glick H, Cost-effectiveness analysis alongside clinical trials II: an ISPOR Good Research Practices Task Force report. Value Health. 2015; 18 (2): 161-172. doi: 10.1016/j.jval.2015.02.001 25773551
30. Drummond MF, Sculpher MJ, Claxton K, Stoddard GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 4th ed. New York, NY: Oxford University Press; 2015.
31. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York, NY: Chapman and Hall/CRC; 1993. doi: 10.1007/978-1-4899-4541-9
32. Polsky D, Glick HA, Willke R, Schulman K. Confidence intervals for cost-effectiveness ratios: a comparison of four methods. Health Econ. 1997; 6 (3): 243-252. doi: 10.1002/(SICI)1099-1050(199705)6:3<243::AID-HEC269>3.0.CO;2-Z 9226142
33. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ. 2001; 10 (8): 779-787. doi: 10.1002/hec.635 11747057
34. Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves: facts, fallacies and frequently asked questions. Health Econ. 2004; 13 (5): 405-415. doi: 10.1002/hec.903 15127421
35. March of Dimes. Peristats. https://www.marchofdimes.org/Peristats/ViewSubtopic.aspx?reg=99&top=3&stop=240&lev=1&slev=1&obj=1. Accessed February 7, 2018.
36. Bastek JA, Langmuir H, Kondapalli LA, Paré E, Adamczak JE, Srinivas SK. Antenatal corticosteroids for late-preterm infants: a decision-analytic and economic analysis. ISRN Obstet Gynecol. 2012; 2012: 491595. doi: 10.5402/2012/491595 23326677
37. Rosenbloom JI, Lewkowitz AK, Sondgeroth KE, Antenatal corticosteroid administration in late-preterm gestations: a cost-effectiveness analysis [published online November 15, 2018]. J Matern Fetal Neonatal Med. 30353764